home.social

#braf — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #braf, aggregated by home.social.

fetched live
  1. Italia @[email protected] ·

    europesays.com/it/615446/ Melanoma: il vaccino su misura che trasforma il sistema immunitario in un esercito contro il tumore #australia #braf #Health #immunoterapia #int #IstitutoNazionaleDeiTumori #IT #Italia #Italy #melanoma #MicheleDelVecchio #milano #Salute #StatiUniti #VacciniAMRNA

    #vacciniamrna #statiuniti #salute #milano #micheledelvecchio #melanoma
  2. Europe @[email protected] ·

    What Ojemda’s JCA reveals about new era of clinical HTA in Europe

    The first published joint clinical assessment (JCA) hands the innovative pharmaceutical industry a working template for a process…
    #Europe #EU #BRAF #clinicalassessment #EUmemberstate #European #HTA #HTAdatabase #JCA #marketingauthorisation #relativeeffectiveness #safetyevaluation
    europesays.com/europe/98509/

    #safetyevaluation #relativeeffectiveness #marketingauthorisation #jca #htadatabase #hta
  3. Europe @[email protected] ·

    Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration

    Ipsen Pharma New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals…
    #Europe #EU #EuropeanCommission #BRAF #pediatricbraintumors #PediatricNeuro-Oncology #systemictherapy #treatmentoption #treatmentoptions
    europesays.com/europe/19691/

    #treatmentoptions #treatmentoption #systemictherapy #pediatricneuro #pediatricbraintumors #braf
  4. Europe @[email protected] ·

    Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration

    New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals over …
    #Europe #EU #alteration #approved #as #BRAF #European #EuropeanUnion #first #glioma #in #low-grade #of #Ojemda® #or #pediatric #refractory #regardless #relapsed #targeted #the #therapy #Union
    europesays.com/europe/19686/

    #union #therapy #the #targeted #relapsed #regardless
  5. Europe @[email protected] ·

    Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration

    Ipsen Pharma New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals…
    #Europe #EU #EuropeanCommission #BRAF #pediatricbraintumors #PediatricNeuro-Oncology #systemictherapy #treatmentoption #treatmentoptions
    europesays.com/europe/19682/

    #treatmentoptions #treatmentoption #systemictherapy #pediatricneuro #pediatricbraintumors #braf
  6. CRAIG M CREWS @[email protected] ·

    Nice preview into mechanisms of #BRaf activation from Arvin Dar and Donita Brady in Mol Cell.
    cell.com/molecular-cell/fullte

    #braf
  7. CRAIG M CREWS @[email protected] ·

    Nice preview into mechanisms of #BRaf activation from Arvin Dar and Donita Brady in Mol Cell.
    cell.com/molecular-cell/fullte

    #braf
  8. CRAIG M CREWS @[email protected] ·

    Nice preview into mechanisms of #BRaf activation from Arvin Dar and Donita Brady in Mol Cell.
    cell.com/molecular-cell/fullte

    #braf